Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.
about
Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complicationsEffectiveness of adding vildagliptin to the treatment of diabetic patients nonresponsive to the combination of metformin and a sulphonylurea.Metabolic Effects of Metformin in the Failing Heart
P2860
Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@en
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@nl
type
label
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@en
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@nl
prefLabel
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@en
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@nl
P2093
P2860
P1476
Comparison of metformin, glicl ...... mbination for type 2 diabetes.
@en
P2093
Amaro Gusmão
Carla Arahata
Clarice Freitas Vilar
José Luciano Albuquerque
Larissa Montenegro
Lidiane Moura e Silva
Lisete Pontes
Lucio Vilar
Maria Juliana Arruda
Rodrigo Agra
P2860
P304
P356
10.1590/S0004-27302010000300010
P577
2010-03-01T00:00:00Z